These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3876561)

  • 1. Quantitative in vivo receptor binding III: Tracer kinetic modeling of muscarinic cholinergic receptor binding.
    Frey KA; Hichwa RD; Ehrenkaufer RL; Agranoff BW
    Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6711-5. PubMed ID: 3876561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative in vivo receptor binding. I. Theory and application to the muscarinic cholinergic receptor.
    Frey KA; Ehrenkaufer RL; Beaucage S; Agranoff BW
    J Neurosci; 1985 Feb; 5(2):421-8. PubMed ID: 3973676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative in vivo receptor binding. II. Autoradiographic imaging of muscarinic cholinergic receptors.
    Frey KA; Ehrenkaufer RL; Agranoff BW
    J Neurosci; 1985 Sep; 5(9):2407-14. PubMed ID: 4032003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative in vivo receptor binding. IV: Detection of muscarinic receptor down-regulation by equilibrium and by tracer kinetic methods.
    Frey KA; Ciliax B; Agranoff BW
    Neurochem Res; 1991 Sep; 16(9):1017-23. PubMed ID: 1784328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of muscarinic cholinergic receptors with [11C]NMPB and positron emission tomography: method development and differentiation of tracer delivery from receptor binding.
    Zubieta JK; Koeppe RA; Mulholland GK; Kuhl DE; Frey KA
    J Cereb Blood Flow Metab; 1998 Jun; 18(6):619-31. PubMed ID: 9626186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo muscarinic cholinergic receptor imaging in human brain with [11C]scopolamine and positron emission tomography.
    Frey KA; Koeppe RA; Mulholland GK; Jewett D; Hichwa R; Ehrenkaufer RL; Carey JE; Wieland DM; Kuhl DE; Agranoff BW
    J Cereb Blood Flow Metab; 1992 Jan; 12(1):147-54. PubMed ID: 1727135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic analysis of 3-quinuclidinyl 4-[125I]iodobenzilate transport and specific binding to muscarinic acetylcholine receptor in rat brain in vivo: implications for human studies.
    Sawada Y; Hiraga S; Francis B; Patlak C; Pettigrew K; Ito K; Owens E; Gibson R; Reba R; Eckelman W
    J Cereb Blood Flow Metab; 1990 Nov; 10(6):781-807. PubMed ID: 2134838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic evaluation of positron-emitting muscarinic receptor ligands employing direct intracarotid injection.
    Buck A; Mulholland GK; Papadopoulos SM; Koeppe RA; Frey KA
    J Cereb Blood Flow Metab; 1996 Nov; 16(6):1280-7. PubMed ID: 8898702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [11C]tropanyl benzilate-binding to muscarinic cholinergic receptors: methodology and kinetic modeling alternatives.
    Koeppe RA; Frey KA; Mulholland GK; Kilbourn MR; Buck A; Lee KS; Kuhl DE
    J Cereb Blood Flow Metab; 1994 Jan; 14(1):85-99. PubMed ID: 8263062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic analysis of transport and opioid receptor binding of [3H](-)-cyclofoxy in rat brain in vivo: implications for human studies.
    Sawada Y; Kawai R; McManaway M; Otsuki H; Rice KC; Patlak CS; Blasberg RG
    J Cereb Blood Flow Metab; 1991 Mar; 11(2):183-203. PubMed ID: 1847702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
    Luthin GR; Wolfe BB
    Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo quantification of cerebral muscarinic receptors in normal human aging using positron emission tomography and [11C]tropanyl benzilate.
    Lee KS; Frey KA; Koeppe RA; Buck A; Mulholland GK; Kuhl DE
    J Cereb Blood Flow Metab; 1996 Mar; 16(2):303-10. PubMed ID: 8594063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ; Tran LP
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic cholinergic receptor binding: in vivo depiction using single photon emission computed tomography and radioiodinated quinuclidinyl benzilate.
    Drayer B; Jaszczak R; Coleman E; Storni A; Greer K; Petry N; Lischko M; Flanagan S
    J Comput Assist Tomogr; 1982 Jun; 6(3):536-43. PubMed ID: 6980235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (R)-N-[11C]methyl-3-pyrrolidyl benzilate, a high-affinity reversible radioligand for PET studies of the muscarinic acetylcholine receptor.
    Skaddan MB; Jewett DM; Sherman PS; Kilbourn MR
    Synapse; 2002 Jul; 45(1):31-7. PubMed ID: 12112411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-in-Human Assessment of
    Naganawa M; Nabulsi N; Henry S; Matuskey D; Lin SF; Slieker L; Schwarz AJ; Kant N; Jesudason C; Ruley K; Navarro A; Gao H; Ropchan J; Labaree D; Carson RE; Huang Y
    J Nucl Med; 2021 Apr; 62(4):553-560. PubMed ID: 32859711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
    Norman AB; Creese I
    Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging muscarinic cholinergic receptors in human brain in vivo with Spect, [123I]4-iododexetimide, and [123I]4-iodolevetimide.
    Müller-Gärtner HW; Wilson AA; Dannals RF; Wagner HN; Frost JJ
    J Cereb Blood Flow Metab; 1992 Jul; 12(4):562-70. PubMed ID: 1618935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic studies of [3H]-N-methylscopolamine binding to muscarinic receptors in the rat central nervous system: evidence for the existence of three classes of binding sites.
    Waelbroeck M; Gillard M; Robberecht P; Christophe J
    Mol Pharmacol; 1986 Oct; 30(4):305-14. PubMed ID: 3762520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of PET ligands (+)N-[(11)C]ethyl-3-piperidyl benzilate and (+)N-[(11)C]propyl-3-piperidyl benzilate for muscarinic cholinergic receptors: a PET study with microdialysis in comparison with (+)N-[(11)C]methyl-3-piperidyl benzilate in the conscious monkey brain.
    Nishiyama S; Tsukada H; Sato K; Kakiuchi T; Ohba H; Harada N; Takahashi K
    Synapse; 2001 Jun; 40(3):159-69. PubMed ID: 11304753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.